Natco Pharma Ltd. (NATP)

Currency in INR
807.00
+10.40(+1.31%)
Closed·

NATP Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy

Technical Indicators

Strong Buy

Moving Averages

Buy

Summary:Strong Buy

Moving Averages:BuyBuy: (10)Sell: (2)
Technical Indicators:Strong BuyBuy: (7)Sell: (1)

Technical Indicators

Summary: Strong BuyBuy: 7Neutral: 3Sell: 1
Nov 6, 2026 10:00 GMT
Name
Value
Action
RSI(14)58.795Buy
STOCH(9,6)46.500Neutral
STOCHRSI(14)37.042Sell
MACD(12,26)5.347Buy
ADX(14)40.224Buy
Williams %R-47.863Neutral
CCI(14)42.7873Neutral
ATR(14)6.7121Less Volatility
Highs/Lows(14)0.6250Buy
Ultimate Oscillator55.932Buy
ROC2.184Buy
Bull/Bear Power(13)6.0870Buy

Moving Averages

Summary: BuyBuy: 10Sell: 2
Nov 6, 2026 10:00 GMT
Name
Simple
Exponential
MA5
808.35
Sell
807.34
Sell
MA10
805.77
Buy
805.54
Buy
MA20
799.96
Buy
801.23
Buy
MA50
791.92
Buy
794.98
Buy
MA100
789.88
Buy
793.90
Buy
MA200
799.94
Buy
802.56
Buy

Pivot Points

Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic802.47804.23805.87807.63809.27811.03812.67
Fibonacci804.23805.53806.33807.63808.93809.73811.03
Camarilla806.57806.88807.19807.63807.81808.12808.44
Woodie's802.40804.20805.80807.60809.20811.00812.60
DeMark's--806.75808.08810.15--

FAQ

From a Technical Analysis Perspective, Is Natco Pharma a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Do the Moving Averages for NATCOPHARM Currently Stand?

The moving averages for Natco Pharma show a Neutral outlook, considering moving averages ranging from MA5 to MA200, with 6 Buy signals and 6 Sell signals.

What Is the Current Status of the Technical Indicators for Natco Pharma?

The technical indicators for Natco Pharma are in a Neutral position based on daily analysis, with 5 signals on buy indicators and 2 sell signals.

What Is NATCOPHARM's 14-Day RSI?

The current Relative Strength Index (RSI) of NATCOPHARM over the 14-day period is 58.795, which suggests that the stock is a Buy.

What Is NATCOPHARM's MACD?

NATCOPHARM's MACD is 5.347, which suggests that the stock is a Buy.

What Is NATCOPHARM's 5-Day Moving Average?

NATCOPHARM's 5-day moving average is 808.35, suggesting that the stock is a Sell.

What Is NATCOPHARM's 50-Day Moving Average?

NATCOPHARM's 50-day moving average is 791.92, suggesting that the stock is a Buy.

What Is NATCOPHARM's 200-Day Moving Average?

NATCOPHARM's 200-day moving average is 799.94, suggesting that the stock is a Buy.

What Is the Fibonacci Pivot Point Performance Value for NATCOPHARM?

The Fibonacci pivot point performance value for NATCOPHARM is 807.63.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.